Bivalent

The FDA revoked the expedited licensing of the first generation of COVID-19 vaccines from Moderna and Pfizer. More than two years have passed since both vaccines, produced under Trump's Operation Warp Speed, were given the green light…

Omicron-targeting bivalent COVID-19 vaccines have been approved for use in newborns as young as six months old, according to US Food and Drug Administration (FDA) announcement on Thursday. FDA Commissioner Robert M. Califf, M.D, said…